Seymour JF, Byrd JC, Ghia P, Kater AP, et al. Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in ELEVATE-RR. Blood 2023 Jun 30:blood.2022018818. doi: 10.1182/blood.2022018818.
PMID: 37390310